Variant report
Variant | nsv526506 |
---|---|
Chromosome Location | chr2:72192369-72206006 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:72194025..72195653-chr2:72198955..72201195,2 | K562 | blood: | |
2 | chr2:72191678..72193899-chr2:72220946..72223503,2 | MCF-7 | breast: | |
3 | chr2:72189932..72192395-chr2:72194287..72196881,3 | K562 | blood: | |
4 | chr2:72189932..72192395-chr2:72194287..72196881,3 | K562 | blood: | |
5 | chr2:72194025..72195653-chr2:72198955..72201195,2 | K562 | blood: | |
6 | chr2:72198746..72201447-chr2:72212541..72214422,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4852828 | chr2:72192369-72192370 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs561928871 | chr2:72192379-72192380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs528154041 | chr2:72192389-72192390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188633383 | chr2:72192420-72192421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191734293 | chr2:72192481-72192482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533291123 | chr2:72192513-72192514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371338195 | chr2:72192515-72192516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535043878 | chr2:72192594-72192595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142932478 | chr2:72192622-72192623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569107463 | chr2:72192627-72192628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555923584 | chr2:72192680-72192681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546603626 | chr2:72192690-72192691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557920103 | chr2:72192782-72192783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs146163012 | chr2:72192803-72192804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs367687338 | chr2:72192865-72192866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140176197 | chr2:72192884-72192885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34771393 | chr2:72192908-72192909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555854926 | chr2:72192924-72192925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574180742 | chr2:72192959-72192960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs200841735 | chr2:72192971-72192972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs544589436 | chr2:72193103-72193104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368372794 | chr2:72193126-72193127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182455470 | chr2:72193136-72193137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs578184448 | chr2:72193157-72193158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143214533 | chr2:72193163-72193164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs560735226 | chr2:72193164-72193165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs111591650 | chr2:72193252-72193253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186902173 | chr2:72193255-72193256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs368857803 | chr2:72193257-72193258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76207353 | chr2:72193295-72193296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561400744 | chr2:72193312-72193313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549116825 | chr2:72193322-72193323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191751616 | chr2:72193343-72193344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144416544 | chr2:72193353-72193354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568796260 | chr2:72193439-72193440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs148430997 | chr2:72193463-72193464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs142544433 | chr2:72193505-72193506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs150989132 | chr2:72193508-72193509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552619707 | chr2:72193530-72193531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs182074708 | chr2:72193574-72193575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs151009969 | chr2:72193581-72193582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs67149272 | chr2:72193582-72193583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555620280 | chr2:72193597-72193598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs62147737 | chr2:72198620-72198621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369804423 | chr2:72198639-72198640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs76459518 | chr2:72198651-72198652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs74550824 | chr2:72198653-72198654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs74385263 | chr2:72198654-72198655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs530623989 | chr2:72198656-72198657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs535842546 | chr2:72198687-72198688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Developmental delay | 21147756 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Myelofibrosis | 22110671 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:72191400-72193600 | Enhancers | Placenta Amnion | Placenta Amnion |
2 | chr2:72192200-72193200 | Enhancers | HSMM | muscle |
3 | chr2:72198600-72199400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr2:72198800-72199000 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr2:72201200-72202800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr2:72201800-72202200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr2:72201800-72202200 | Enhancers | NHDF-Ad | bronchial |